SkyView Investment Advisors’s AstraZeneca AZN Stock Holding History

SkyView Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.41M	Buy	7,141 +51	+0.7%	+$9.83K	0.19%	73
2025 Q4	$1.3M	Sell	7,090 -104	-1%	-$18.2K	0.16%	80
2025 Q3	$1.1M	Buy	7,194 +86	+1%	+$13K	0.14%	104
2025 Q2	$993K	Sell	7,108 -1,909	-21%	-$268K	0.14%	117
2025 Q1	$1.32M	Buy	9,017 +436	+5%	+$63.1K	0.2%	77
2024 Q4	$1.12M	Buy	+8,581	New	+$1.2M	0.18%	85
2024 Q3	–	Sell	-5,496	Closed	-$857K	–	308
2024 Q2	$857K	Buy	5,496 +36	+0.7%	+$5.42K	0.15%	109
2024 Q1	$740K	Buy	+5,460	New	+$723K	0.14%	129
2023 Q4	–	Sell	-4,276	Closed	-$579K	–	182
2023 Q3	$579K	Buy	4,276 +229	+6%	+$31.3K	0.24%	120
2023 Q2	$579K	Buy	+4,047	New	+$595K	0.14%	187

Other funds holding AZN

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Asset Management London, Ec4n 8af $148B AUM

SkyView Investment Advisors's AZN Position: Q1 2026 in Review

SkyView Investment Advisors increased its AstraZeneca (AZN) stake by 0.72% in Q1 2026, buying an estimated $9.83K and bringing the position to 7,141 shares worth $1.41M. The position accounts for 0.19% of the portfolio, ranked #73.

SkyView Investment Advisors first reported a position in AZN in Q2 2023 and has held it in 10 quarters since. 1,386 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

SkyView Investment Advisors held 7,141 shares of AstraZeneca worth $1.41M as of Q1 2026.
SkyView Investment Advisors bought 51 AstraZeneca shares in Q1 2026, an estimated $9.83K.
AstraZeneca made up 0.19% of SkyView Investment Advisors's portfolio in Q1 2026, its #73 holding.
SkyView Investment Advisors first reported a position in AstraZeneca in Q2 2023 and has held it in 10 quarters since.
1,386 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on SkyView Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.